Chinese Journal of Cancer Research

Papers
(The median citation count of Chinese Journal of Cancer Research is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomas58
Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial49
Gastric cancer surgery in South Korea: Past, present, and future34
Efficacy of ctDNA methylation combined with traditional detection modality to detect liver cancer among high-risk patients: A multicenter diagnostic trial34
Transforming cancer cells for long-term living with cancer: An inspiring new approach33
Pathogenic germline variants in mismatch repair genes in patients with microsatellite instability-high gastric cancer32
Focal ablation therapy presents promising results for selectively localized prostate cancer patients30
Heterogeneity of tumor-infiltrating myeloid cells in era of single-cell genomics29
Clinical and molecular significance of homologous recombination deficiency positive non-small cell lung cancer in Chinese population: An integrated genomic and transcriptional analysis28
Detection and classification of breast lesions using multiple information on contrast-enhanced mammography by a multiprocess deep-learning system: A multicenter study23
National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)23
Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives23
Mn-based cGAS-STING activation for tumor therapy23
Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumors22
Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A20
Prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery: Final results of a phase II trial15
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China14
Hypoxic tumor microenvironment: Destroyer of natural killer cell function14
Health economic evaluation on population-based Helicobacter pylori eradication and endoscopic screening for gastric cancer prevention14
A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma14
New roles of tumor-derived exosomes in tumor microenvironment14
Optimal response population after neoadjuvant therapy for patients with locally advanced gastric cancer: A multicenter study14
Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study12
Burden of liver cancer: From epidemiology to prevention12
Corrigendum to Comments on National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)12
Postoperative chemoradiotherapy with capecitabine and oxaliplatin vs. capecitabine for pathological stage N2 rectal cancer11
Genomic characterization of peritoneal lavage cytology-positive gastric cancer11
Pan-cancer tumor-infiltrating T cells: A great hallmark in cancer immunology research11
Lung cancer burden and trends from 2000 to 2018 in China: Comparison between China and the United State10
Estimation of economic burden throughout course of cervical squamous intraepithelial lesion and cervical cancer in China: A nationwide multicenter cross-sectional study10
Research progress of minimally invasive surgery for gastric cancer10
Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors10
Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS) mutant tumors9
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer9
Comments on National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)9
Adjuvant therapy for hormone receptor-positive breast cancer: Perspective from a survey on breast cancer physicians’ acceptance of practice-changing data8
SOX11 as a potential prognostic biomarker in hepatocellular carcinoma linked to immune infiltration and ferroptosis7
Advances, breakthroughs, and challenges in gastric cancer surgery7
Clinicopathological and molecular features of HR+/HER2− breast cancer patients with distinct endocrine resistance patterns6
Predictive value of co-expression patterns of immune checkpoint molecules for clinical outcomes of hematological malignancies6
Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression6
Postoperative functional evaluation of gastrectomy for gastric cancer5
Inducing immunogenic cell death in immuno-oncological therapies5
Update of latest data for combined therapy for esophageal cancer using radiotherapy and immunotherapy: A focus on efficacy, safety, and biomarkers5
Laparoscopic vs. open lower mediastinal lymphadenectomy for Siewert type II/III adenocarcinoma of esophagogastric junction: An exploratory, observational, prospective, IDEAL stage 2b cohort study (CLA5
Distal margin distance in radical resection of locally advanced rectal cancer after neoadjuvant therapy5
Efficacy and safety of dacomitinib as first-line treatment for advanced non-small cell lung cancer patients with epidermal growth factor receptor 21L858R mutation: A multicenter, case-series study in 5
Nonoperative management of gastrointestinal malignancies in era of neoadjuvant treatment5
Myeloid cells meet CD8+ T cell exhaustion in cancer: What, why and how4
Manufacturing CAR-NK against tumors: Who is the ideal supplier?4
Prognostic implications of tumor-infiltrating lymphocytes in association with programmed cell death ligand 1 expression in remnant gastric cancer4
Efficacy, safety, and multi-omics analysis of pembrolizumab combined with nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carci4
Genomic landscape of T-cell lymphoblastic lymphoma4
Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II s4
Neoadjuvant chemotherapy with capecitabine combined with oxaliplatin for mid-low locally advanced rectal cancer with negative mesorectal fascia: Long-term outcomes of a prospective trial (PKUCH-R03 tr4
Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis4
Subpopulation cooperation renders drug resistance of hepatobiliary tumor organoids4
CSCO guidelines for colorectal cancer version 2023: Updates and insights3
CT-based radiomics-deep learning model predicts occult lymph node metastasis in early-stage lung adenocarcinoma patients: A multicenter study3
Reprogramming of fatty acid metabolism in thyroid cancer: Potential targets and mechanisms3
A multicenter study on the efficacy of dual-target neoadjuvant therapy for HER2-positive breast cancer and a consistent analysis of the efficacy evaluation of neoadjuvant therapy by Miller-Payne and R3
Coupling radiomics analysis of CT image with diversification of tumor ecosystem: A new insight to overall survival in stage I−III colorectal cancer3
Pyrotinib is effective in both trastuzumab-sensitive and primary resistant HER2-positive breast tumors3
New insights into mechanisms and interventions of locoregional therapies for hepatocellular carcinoma3
Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer3
National validation of laparoscopic approach for locally advanced gastric cancer: Comparison of a randomized controlled trial and real-world practice results3
National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)3
Establishment of an optimized CTC detection model consisting of EpCAM, MUC1 and WT1 in epithelial ovarian cancer and its correlation with clinical characteristics3
Management guidelines for preventing exposure to antineoplastics2
Epidemiology of pancreatic cancer: New version, new vision2
Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma2
A phase I study of Hemay022, an irreversible dual EGFR/HER2 tyrosine kinase inhibitor in Chinese patients with HER2-positive advanced breast cancer2
IMpower210: A phase III study of second-line atezolizumab vs. docetaxel in East Asian patients with non-small cell lung cancer2
A novel multimodal prediction model based on DNA methylation biomarkers and low-dose computed tomography images for identifying early-stage lung cancer2
Microbiota in colorectal cancer related to liver metastasis2
Corrigendum to Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm cli2
National guidelines for diagnosis and treatment of melanoma 2022 in China (English version)2
Adaptive neoadjuvant endocrine therapy screens out prime population of ribociclib intensive adjuvant therapy2
MRD-directed and risk-adapted individualized stratified treatment of AML2
Advances in surgical techniques for gastric cancer: Indocyanine green and near-infrared fluorescence imaging. Is it ready for prime time?2
Enhancing diagnostic accuracy: Role of stomach-specific serum biomarkers in real-world risk-based sequential screening for malignant gastric lesions2
A multi-center, open-label, randomized, parallel-controlled phase II study comparing pharmacokinetic, pharmacodynamics and safety of ripertamab (SCT400) to rituximab (MabThera� in patients with CD20-p2
Evolution of laparoscopic gastrectomy for cancer in the East and West1
Inspired by novel radiopharmaceuticals: Rush hour of nuclear medicine1
Comments on National guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version)1
Exploring ideal operative time for best outcomes in gastric cancer surgery: A multi-institutional study based on KLASS-07 database1
Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small cell lung cancer: A real-world, multicenter, retrospective, controlled study in China1
Context-dependent roles of 5-HT and its receptors in tumor growth and wound healing: Mechanisms and therapeutic implications1
Preface to Special Issue: Cancer epidemiology, risk factors and screening1
Systematic functional interrogation of genome-wide association studies locus 17p13.3 deciphered role and genetic control of FAM57A in colorectal cancer development1
National guidelines for diagnosis and treatment of lung cancer 2022 in China (English version)1
Aqueous-soluble components of sporoderm-removed Ganoderma lucidum spore powder promote ferroptosis in oral squamous cell carcinoma1
Nucleotide excision repair gene polymorphisms and hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study1
When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road1
Challenge and future of cancer screening in China: Insights from esophageal cancer screening practice1
Efficacy analysis of Cheng’s GIRAFFE reconstruction after proximal gastrectomy for adenocarcinoma of esophagogastric junction1
Advances in gastric cancer treatment in 2024: Key advancements and emerging trends1
Integrated clinical-radiomic model for predicting treatment response of concurrent chemo-radiotherapy and radiotherapy alone in controversial subgroup of AJCC/UICC ninth edition stage I nasopharyngeal1
Artificial intelligence efficiently predicts gastric lesions, Helicobacter pylori infection and lymph node metastasis upon endoscopic images1
Global, regional, and national burden of colorectal cancer, 1990−2021: An analysis from global burden of disease study 20211
Circulating tumor DNA and its role in detection, prognosis and therapeutics of hepatocellular carcinoma1
Targeted activation of junctional adhesion molecule-like protein+ CD8+ T cells enhances immunotherapy in hepatocellular carcinoma1
0.080451965332031